Furthermore, EpCAM is capable of enriching, identifying, and characterizing metastatic cells that spread from primary tumors into the fluids of patients with advanced cancer (Treitschke et al., 2023; Mederer et al., 2022). The gene discussed is EPCAM; the disease is cancer.